Methyl 2-tetradecylglycidate, an orally effective hypoglycemic agent that inhibits long chain fatty acid oxidation selectively.
D000818:Animals; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism; D003964:Diaphragm / Q000187:drug effects / Q000378:metabolism; D004852:Epoxy Compounds / Q000494:pharmacology*; D004988:Ethers, Cyclic / Q000494:pharmacology*; D005227:Fatty Acids / Q000378:metabolism*; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007672:Kidney Cortex / Q000187:drug effects / Q000378:metabolism; D007700:Kinetics; D010084:Oxidation-Reduction; D010169:Palmitic Acids / Q000378:metabolism; D011422:Propionates / Q000494:pharmacology*; D051381:Rats; D013329:Structure-Activity Relationship
D004852:Epoxy Compounds; D004988:Ethers, Cyclic; D005227:Fatty Acids; D007004:Hypoglycemic Agents; D010169:Palmitic Acids; D011422:Propionates; C017522:methyl 2-tetradecylglycidate